Healthcare provider profile · identity verified

Lyle E Wadsworth, MD

Internal Medicine · DELAND, FL · NPI 1356347561

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	417	102
Levothyroxine Sodium	Levothyroxine Sodium	359	75
Amlodipine Besylate	Amlodipine Besylate	322	78
Furosemide	Furosemide	256	60
Eliquis	Apixaban	232	36
Lisinopril	Lisinopril	163	49
Duloxetine Hcl	Duloxetine Hcl	160	35
Tamsulosin Hcl	Tamsulosin Hcl	160	39
Metoprolol Tartrate	Metoprolol Tartrate	146	30
Gabapentin	Gabapentin	145	36
Rosuvastatin Calcium	Rosuvastatin Calcium	142	32
Pantoprazole Sodium	Pantoprazole Sodium	137	40
Valsartan	Valsartan	130	35
Metoprolol Succinate	Metoprolol Succinate	129	38
Spironolactone	Spironolactone	117	27
Alendronate Sodium	Alendronate Sodium	115	30
Tramadol Hcl	Tramadol Hcl	106	30
Zolpidem Tartrate	Zolpidem Tartrate	105	29
Metformin Hcl	Metformin Hcl	104	31
Clopidogrel	Clopidogrel Bisulfate	102	25
Lorazepam	Lorazepam	99	33
Omeprazole	Omeprazole	98	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	97	24
Alprazolam	Alprazolam	93	21
Losartan Potassium	Losartan Potassium	89	28
Prednisone	Prednisone	80	31
Trazodone Hcl	Trazodone Hcl	80	21
Pregabalin	Pregabalin	77	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	74	27
Oxybutynin Chloride Er	Oxybutynin Chloride	72	16
Simvastatin	Simvastatin	72	15
Sertraline Hcl	Sertraline Hcl	67	30
Citalopram Hbr	Citalopram Hydrobromide	66	17
Topiramate	Topiramate	64	20
Donepezil Hcl	Donepezil Hcl	61	15
Diclofenac Sodium	Diclofenac Sodium	60	suppressed
Potassium Chloride	Potassium Chloride	58	16
Meloxicam	Meloxicam	54	15
Triamcinolone Acetonide	Triamcinolone Acetonide	54	18
Levofloxacin	Levofloxacin	50	32
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	50	27
Pravastatin Sodium	Pravastatin Sodium	50	14
Finasteride	Finasteride	45	suppressed
Mirtazapine	Mirtazapine	45	11
Atenolol	Atenolol	44	suppressed
Allopurinol	Allopurinol	43	14
Methylprednisolone	Methylprednisolone	43	33
Carvedilol	Carvedilol	42	13
Ozempic	Semaglutide	42	suppressed
Ropinirole Hcl	Ropinirole Hcl	41	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	40	suppressed
Celecoxib	Celecoxib	39	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	39	suppressed
Montelukast Sodium	Montelukast Sodium	39	11
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	21
Meclizine Hcl	Meclizine Hcl	37	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	36	12
Ibuprofen	Ibuprofen	36	suppressed
Glipizide Er	Glipizide	35	suppressed
Levetiracetam	Levetiracetam	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Latanoprost	Latanoprost	32	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Azithromycin	Azithromycin	31	26
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Cephalexin	Cephalexin	28	16
Nystatin	Nystatin	28	14
Temazepam	Temazepam	27	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Glimepiride	Glimepiride	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Divalproex Sodium	Divalproex Sodium	23	suppressed
Estradiol	Estradiol	23	suppressed
Naproxen	Naproxen	23	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	22	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Methadone Hcl	Methadone Hcl	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	20	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	20	suppressed
Midodrine Hcl	Midodrine Hcl	20	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	20	suppressed
Glipizide	Glipizide	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	13
Risperidone	Risperidone	19	suppressed
Clotrimazole	Clotrimazole	18	11
Dutasteride	Dutasteride	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Brimonidine Tartrate	Brimonidine Tartrate	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Lacosamide	Lacosamide	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Baclofen	Baclofen	15	suppressed
Calcitriol	Calcitriol	15	suppressed
Digoxin	Digoxin	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Nitroglycerin	Nitroglycerin	14	11
Oxcarbazepine	Oxcarbazepine	14	suppressed
Primidone	Primidone	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Colchicine	Colchicine	13	suppressed
Diazepam	Diazepam	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Glucagon Emergency Kit	Glucagon	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error